Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Nichols

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
European Urology|January 18, 2018
Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and SummaryPhillip Martin Pierorazio, Peter Albers, Peter C Black, et al.
Frontiers in Oncology|October 25, 2021
Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell CancerXiaosong Meng, Murtaza Ahmed, Kevin D Courtney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgeryChristian Kollmannsberger, Siamak Daneshmand, Alan So, et al.
European Urology|September 4, 2012
Contemporary management of postchemotherapy testis cancerSiamak Daneshmand, Peter Albers, Sophie Dorothea Fosså, et al.
Plos One|May 9, 2025
Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumorsArkhjamil Angeles, Nastaran Khazamipour, Gurdial Dhillon, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOGDon S Dizon, Mina S Sedrak, Mark A Lewis, et al.
International Immunopharmacology|June 16, 2007
Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell productsRakesh K Singh, Michelle L Varney, Cheryl Leutzinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual diseaseJulie M Vose, Graham Sharp, Wing C Chan, et al.
The Oncologist|September 27, 2022
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell TumorsJack V W Bacon, Patrizia Giannatempo, Giovanna Cataldo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphomaArnold Freedman, Sattva S Neelapu, Craig Nichols, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
European Urology|January 18, 2018
Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and SummaryPhillip Martin Pierorazio, Peter Albers, Peter C Black, et al.
Frontiers in Oncology|October 25, 2021
Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell CancerXiaosong Meng, Murtaza Ahmed, Kevin D Courtney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgeryChristian Kollmannsberger, Siamak Daneshmand, Alan So, et al.
European Urology|September 4, 2012
Contemporary management of postchemotherapy testis cancerSiamak Daneshmand, Peter Albers, Sophie Dorothea Fosså, et al.
Plos One|May 9, 2025
Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumorsArkhjamil Angeles, Nastaran Khazamipour, Gurdial Dhillon, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOGDon S Dizon, Mina S Sedrak, Mark A Lewis, et al.
International Immunopharmacology|June 16, 2007
Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell productsRakesh K Singh, Michelle L Varney, Cheryl Leutzinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual diseaseJulie M Vose, Graham Sharp, Wing C Chan, et al.
The Oncologist|September 27, 2022
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell TumorsJack V W Bacon, Patrizia Giannatempo, Giovanna Cataldo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphomaArnold Freedman, Sattva S Neelapu, Craig Nichols, et al.
Pageof 5